96
Views
0
CrossRef citations to date
0
Altmetric
Articles

Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required

, ORCID Icon, , ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • World Healh Organization. Global programme to eliminate lymphatic filariasis: progress report, 2016. Wkly Epidemiol Rec. 2017;92(40):594–607.
  • World Health Organization. Strengthening the assessment of lymphatic filariasis transmission and documenting the achievement of elimination: meeting of the neglected tropical diseases strategic and technical advisory group’s monitoring and evaluation subgroup on disease-specific indicators. Geneva: 2016.
  • Ottesen EA, Duke BO, Karam M, et al. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491–503.
  • Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health. 2000;5(9):591–594.
  • World Healh Organization. Global programme to eliminate lymphatic filariasis: progress report. Wkly Epidemiol Rec. 2015;91(39):489–504.
  • Ichimori K, King JD, Engels D, et al. Global programme to eliminate lymphatic filariasis: the processes underlying programme success. PLoS Negl Trop Dis. 2014;8(12):e3228.
  • Aguiar-Santos AM, Medeiros Z, Bonfim C, et al. Epidemiological assessment of neglected diseases in children: lymphatic filariasis and soil-transmitted helminthiasis. J Pediatr (Rio J). 2013;89(3):250–255.
  • Rocha A, Dos Santos EM, Oliveira P, et al. History of lymphatic filariasis control actions in Olinda, Pernambuco, Brazil. Rev Patol Trop 2016;45(4):339–348.
  • Center for Disease Control and Prevenion. Lymphatic Filariasis: Elimination in the Americas. 2011
  • Pernambuco. Secretaria Estadual de Saúde. Secretaria Executiva deVigilância em Saúde. Plano Integrado de Ações para o Enfretamento àsDoenças Negligenciadas no Estado de Pernambuco/ SANAR – 2015-2018 / Secretaria Estadual de Saúde. Secretaria Executiva de Vigilância em Saúde. Recife: Secretaria Estadual de Saúde. 2015
  • Departamento de Saúde de Jaboatão dos Guararapes, unpublished data.
  • Bonfim CV, Netto MJE, Pedroza D, et al. A socioenvironmental composite index as a tool for identifying urban areas at risk of lymphatic filariasis. Trop Med Int Health. 2009;14(8):877–884.
  • Brandão E, Bonfim C, Cabral D, et al. Mapping of Wuchereria bancrofti infection in children and adolescents in an endemic area of Brazil. Acta Trop. 2011;120:151–154.
  • Weil GJ, Ramzy RMR. Diagnostic tools for filariasis elimination programs. Trends Parasitol. 2007;23(2):78–82.
  • Rebollo MP, Bockarie MJ. Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring. Parasitology. 2014;141(14):1912–1917.
  • McMahon TF, Marshall JP, Vaughan DE. Bancroftian filariasis: a comparison of microfilariae counting techniques using counting chamber, standard slide and membrane (nuclepore) filtration. Ann Trop Med Parasitol. 1979;73:457–464.
  • Rocha A, Lima G, Medeiros Z, et al. Circulating filarial antigen in the hydrocele fluid from individuals living in a bancroftian filariasis area - Recife, Brazil - Detected by the monoclonal antibody Og4C3-assay. Mem Inst Oswaldo Cruz. 2004;99(1):101–105.
  • Dreyer G, Pimentael A, Medeiros Z, et al. Studies on the periodicity and intravascular distribuiton of Wuchereria bancrofti microfilariae in paired samples of capillary and venous blood from Recife, Brazil. Trop Med Int Health. 1996;1(2):264–272.
  • Fox LM, Furness BW, Haser JK, et al. Ultrasonographic examination of Haitian children with lymphatic filariasis: A longitudinal assessment in the context of antifilarial drug treatment. Am J Trop Med Hyg. 2005;72(5):642–648.
  • More S, Copeman D. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol. 1990;41(4):43–46.
  • Chesnais CB, Missamou F, Pion SD, et al. Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen. Am J Trop Med Hyg. 2013;89(5):916–918.
  • Weil GJ, Curtis KC, Fakoli L, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg. 2013;89(1):11–15.
  • Kubofcik J, Fink DL, Nutman TB. Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis. 2012;6(12):e1930.
  • Weil GJ, Curtis KC, Fischer PU, et al. A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. Acta Trop. 2011;120(1):S19–22.
  • Nunes LV, Rocha A, Araújo J, et al. Lymphatic filariasis: surveillance action among immigrants from endemic areas, Acre state, Brazilian Amazon. Asian Pacific J Trop Dis. 2016;6(7):521–526.
  • Netto MJ, Bonfim C, Brandão E, et al. Burden of lymphatic filariasis morbidity in an area of low endemicity in Brazil. Acta Trop. 2016;163:54–660.
  • Gounoue-Kamkumo R, Nana-Djeunga HC, Bopda J, et al. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures. BMC Infect Dis. 2015;15:579–586.
  • Won KY, Robinson K, Hamlin KL, et al. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa. PloS Negl Trop Dis. 2018;12(3):e0006347.
  • Braga C, Dourado MI, Ximenes RA, et al. Field evaluation of the whole blood immunochromatographic test for rapid bancroftian filariasis diagnosis in the northeast of Brazil. Rev Inst Med Trop Sao Paulo. 2003;45(3):125–129.
  • Simonsen PE, Magesa SM. Observations on false positive reactions in the rapid NOW filariasis card test. Trop Med Int Health. 2004;9:1200–1202.
  • Pastor AF, Rocha A, Cassemiro KD, et al. Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis. Memórias Inst Oswaldo Cruz. 2018;113(5):1–8.
  • Dorkenoo, Bronzan R, Yehadji D, et al. Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010–2015. Parasit Vectors. 2018;11(1):244–252.
  • Sheel M, Sheridan S, Gass K, et al. Identifying residual transmission of lymphatic filariasis after mass drug administration: comparing schoolbased versus community-based surveillance - American Samoa. PLoS Negl Trop Dis. 2016;12(7):e00006583.
  • Brant TA, Okorie PN, Ogunmola O, et al. Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria. Parasite Epidemiol Control. 2018;28(3):21–35.
  • Mehta PK, Rauniyar R, Gupta BP. Microfilaria persistent foci during post MDA and the risk assessment of resurgence in India. Trop Med Health. 2018;46(25):1–6.
  • Chandrasena N, Premaratna R, Gunaratna IE, et al. Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: current status and future prospects. PLoS Negl Trop Dis. 2018;12(5):e0006472.
  • Shenoy RK. Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol. 2008;46(3):119–125.
  • Harris JR, Wiegand RE. Detecting infection hotspots: modeling the surveillance challenge for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2017;11(5):e0005610.
  • World Healh Organization. Validation of elimination of lymphatic filariasis as a public health problem. WHO Guidance & Forms. 2017
  • Fontes G, Rocha EM, Brito AC, et al. Lymphatic Filariasis in Brazilian Urban Area (Maceió, Alagoas). Memórias Inst Oswaldo Cruz. 1998;93(6):705–710.
  • Freitas H., Vieira JB, Braun R, et al. Workshop para avaliação da situação epidemiológica da filariose linfática no Município de Belém, PA. Rev Soc Bras Med Trop. 2008;41(2):212–216.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.